title: Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome.
abstract: Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome.
authors.affiliation: Instituto do Cérebro, Porto Alegre, Brazil.
authors.forename: Luiz Carlos Porcello
authors.initials: LC
authors.lastname: Marrone
authors.forename: Bianca Fontana
authors.initials: BF
authors.lastname: Marrone
authors.forename: Julia
authors.initials: J
authors.lastname: de la Puerta Raya
authors.forename: Giovani
authors.initials: G
authors.lastname: Gadonski
authors.forename: Jaderson Costa
authors.initials: JC
authors.lastname: da Costa